In connection with the Offering, the Agents were paid a cash fee as set out in the Agency Agreement in an amount equal to 6.0% of the gross proceeds of the Offering.

Renovaro Inc. (NASDAQ: RENB), an AI-driven precision Medicine Company that leverages AI platforms to improve outcomes for cancer and neurologically challenged patients, today announced is expanding ...